Emory University Opposition, Lamivudine (3 Tc) , (Ep90301335)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Indian Network of People Living with HIV/AIDS (INP+) and Manipur Network of Positive People (MNP+) opposition, zidovudine/lamivudine (AZT/3TC) , (2044/CAL/1997)
Countries: India Date: 2006
-
AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Dolutegravir/Abacavir/Lamivudine , (TH1201003753)
Countries: Thailand Date: 2017
-
LEK Pharmaceuticals opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
Page White & Farrer opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
ter Meer Steinmeister & Partner opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
Apotex Corp opposition, Zidovudine/Lamivudine/Abacavir, (US6417191)
Countries: United States of America Date: 2015
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, lopinavir/ritonavir (LPV/r) , (339/MUMNP/2006)
Countries: India Date: 2007
-
Cipla Ltd. opposition, lopinavir/ritonavir (LPV/r) , (726/MUMNP/2009 (Divisional of 339/MUMNP/2006))
Countries: India Date: 2010
-
Matrix Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (2474/DELNP/2009 (Divisional of 339/MUMNP/2006))
Countries: India Date: 2010
-
Ranbaxy Laboratories opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)
Countries: India Date: 2005